This is consistent with recent studies reporting FoxQ1 overexpression in breast cancer [4, 6] and colorectal cancer [6, 10], and that high expression of FoxQ1 enhanced tumorigenicity and tumor growth [10]. The gene discussed is FOXQ1; the disease is colorectal cancer.